ES2157949T3 - Suspension oftalmica que contiene difluprednato. - Google Patents

Suspension oftalmica que contiene difluprednato.

Info

Publication number
ES2157949T3
ES2157949T3 ES94120480T ES94120480T ES2157949T3 ES 2157949 T3 ES2157949 T3 ES 2157949T3 ES 94120480 T ES94120480 T ES 94120480T ES 94120480 T ES94120480 T ES 94120480T ES 2157949 T3 ES2157949 T3 ES 2157949T3
Authority
ES
Spain
Prior art keywords
ophthalmic suspension
suspension containing
conjunctivitis
suspension
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94120480T
Other languages
English (en)
Inventor
Motoko Kimura
Yasushi Morita
Takahiro Ogawa
Tadashi Terai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Mitsubishi Chemical Corp
Original Assignee
Senju Pharmaceutical Co Ltd
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Mitsubishi Chemical Corp filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2157949T3 publication Critical patent/ES2157949T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

UNA SUSPENSION OFTALMICA COMPRENDIENDO DIFLUPREDONATO COMO UN INGREDIENTE ACTIVO. LA SUSPENSION OFTALMICA DE LA PRESENTE INVENCION MUESTRA ACCION ANTIINFLAMATORIA Y ACCION ANTIALERGICA SUPERIOR POR LA ADMINISTRACION LOCAL. DE ACUERDO CON LA INVENCION, LA SUSPENSION DE LA PRESENTE INVENCION ES UTIL PARA EL TRATAMIENTO Y PREVENCION DE ENFERMEDADES DEL OJO, TALES COMO CONJUNTIVITIS ALERGICA, CONJUNTIVITIS VERNAL, BLEFARITIS MARGINALES, CONJUNTIVITIS CATARRAL Y UVEITIS.
ES94120480T 1993-12-27 1994-12-23 Suspension oftalmica que contiene difluprednato. Expired - Lifetime ES2157949T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33209993 1993-12-27

Publications (1)

Publication Number Publication Date
ES2157949T3 true ES2157949T3 (es) 2001-09-01

Family

ID=18251141

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94120480T Expired - Lifetime ES2157949T3 (es) 1993-12-27 1994-12-23 Suspension oftalmica que contiene difluprednato.

Country Status (10)

Country Link
US (1) US5556848A (es)
EP (1) EP0659433B1 (es)
KR (1) KR950016758A (es)
CN (1) CN1122225A (es)
AT (1) ATE202477T1 (es)
AU (1) AU684115B2 (es)
CA (1) CA2138741A1 (es)
DE (1) DE69427573T2 (es)
ES (1) ES2157949T3 (es)
TW (1) TW327602B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10251131A (ja) * 1997-03-11 1998-09-22 Sunstar Inc 口腔用組成物
US6114319A (en) * 1997-05-14 2000-09-05 Senju Pharmaceutical Co., Ltd. Compositions containing difluprednate
WO1998057646A1 (fr) * 1997-06-19 1998-12-23 Senju Pharmaceutical Co., Ltd. Preparations medicinales aqueuses a base de difluprednate solubilise destinees a un usage externe
JP4255656B2 (ja) * 2001-09-17 2009-04-15 株式会社メニコン 眼科用液剤及びコンタクトレンズ用液剤
KR20100132557A (ko) * 2002-08-23 2010-12-17 산텐 세이야꾸 가부시키가이샤 라타노프로스트를 유효 성분으로 하는 점안액의 안정화 방법
US20040167109A1 (en) * 2003-02-20 2004-08-26 Bingaman David P Formulations of glucocorticoids to treat pathologic ocular angiogenesis
US20050084454A1 (en) * 2003-10-14 2005-04-21 Sinofresh Healthcare, Inc. Compositions and methods for cleaning nasal cavities
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
FR2891460B1 (fr) * 2005-09-30 2010-07-30 Galderma Sa Utilisation d'au moins un compose de la famille des avermectines pour le traitement des pathologies ophtalmiques dues au demodex folliculorum.
WO2007127333A2 (en) * 2006-04-26 2007-11-08 Aciex, Inc. Compositions for the treatment and prevention of eyelid swelling
TWI415629B (zh) 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法
TW201105363A (en) 2009-07-14 2011-02-16 Univ Yamagata Eye drop for macular edema treatment
WO2013098841A1 (en) 2011-10-31 2013-07-04 Fdc Limited Nanodispersion of poorly water soluble drug(s)
EP3250185B1 (en) * 2015-01-26 2018-12-05 Bausch & Lomb Incorporated Ophthalmic suspension composition
CA3001955C (en) * 2015-10-16 2023-11-28 Sun Pharma Advanced Research Company Limited Ophthalmic solution of difluprednate
BR112018072664A2 (pt) * 2016-05-05 2019-02-19 Veloce Biopharma, Llc composições e métodos para tratamento de inflamação e infecção do olho
US10610499B2 (en) * 2016-05-06 2020-04-07 SaCSh Corp. Ophthalmic compositions
JP2024501425A (ja) * 2020-12-03 2024-01-12 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 眼炎症の有害作用を軽減するためのジフルプレドナート

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
US3784692A (en) * 1967-06-16 1974-01-08 Warner Lambert Co 17-propionate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
JPS61167614A (ja) * 1985-01-22 1986-07-29 Mitsubishi Yuka Yakuhin Kk ステロイド含有軟膏剤
US5407926A (en) * 1987-12-29 1995-04-18 Alcon Laboratories, Inc. Ophthalmic composition
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
JPH0543465A (ja) * 1991-08-08 1993-02-23 Mitsubishi Kasei Corp コルチコステロイド含有ローシヨン剤

Also Published As

Publication number Publication date
KR950016758A (ko) 1995-07-20
CN1122225A (zh) 1996-05-15
ATE202477T1 (de) 2001-07-15
US5556848A (en) 1996-09-17
AU8160194A (en) 1995-07-06
AU684115B2 (en) 1997-12-04
EP0659433A1 (en) 1995-06-28
CA2138741A1 (en) 1995-06-28
EP0659433B1 (en) 2001-06-27
DE69427573D1 (de) 2001-08-02
TW327602B (en) 1998-03-01
DE69427573T2 (de) 2002-04-25

Similar Documents

Publication Publication Date Title
ES2157949T3 (es) Suspension oftalmica que contiene difluprednato.
AU2003274734A1 (en) Method and composition containing latanoprost for treating ocular hypertension and glaucoma
DK0725779T3 (da) Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner
ATE198708T1 (de) Verwendung von makrolid-verbindungen gegen augenerkrankungen
DK0799044T3 (da) Topiske oftalmologiske formuleringer indeholdende olopatidin til behandling af allergiske øjensygdomme
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
NO180632C (no) 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler
DK0556329T3 (da) Substituerede piperaziner som midler til behandling af centralnervesystemet
ATE162074T1 (de) Oculare hypotensive mittel
DK0824916T3 (da) Pranoprofenøjendråber indeholdende organisk amin
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
ATE271390T1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
NO913331D0 (no) 4-substituerte dihydropyrido(4,3-d)pyrimidiner for behandling av hudforstyrrelser.
NO176097C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksener
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
RU94045256A (ru) Применение бензо[g]хинолинов
KR950002761A (ko) 강박 반응 장애 치료제 제조용으로서의 n-(피리디닐)-1h-인돌-1-아민의 용도
NO179472C (no) Opplösning omfattende benzoxoniumklorid for behandling av kontaktlinser, og anvendelse derav til konservering av kontaktlinser og legemidler for öynene
HUT46921A (en) Process for producing 3-phenyl-7h-thiazolo /3,2-b//1,2,4/ triazin-7-ones, certain intermediaries thereof and pharmaceutics comprising such active ingredient
DE69015411D1 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
DE69327077T2 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
IL111922A0 (en) Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylates, their preparation and pharmaceutical com¦ositions containing them

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 659433

Country of ref document: ES